Home › NDC Lookup › RxCUI directory › RxCUI 2674932

0.25 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz] — RxCUI 2674932

RxNorm drug concept · Semantic branded drug
RxCUI 2674932 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2674932
Official name0.25 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.25 ML Taltz 80 MG/ML Prefilled Syringe; taltz 20 MG in 0.25 ML Prefilled Syringe; Taltz 20 MG per 0.25 ML Prefilled Syringe
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)72,831 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ixekizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Taltz is approved for moderate-to-severe plaque psoriasis in people aged 6 and older, and for adults with psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spo...
  • No, most adults can give themselves the shot at home after being trained by their healthcare provider. You use either the Taltz autoinjector or prefilled syringe and inject under t...
  • How do I give myself the injection — do I need to go to a clinic every time?
  • The most common things people notice are redness or soreness at the injection site, upper respiratory infections like a runny nose, nausea, or fungal infections like thrush. Those...
📖 Read our full Ixekizumab Injection guide →

🕸️ Concept Web — How 0.25 ML ixekizumab 80 MG/ML Prefilled Syringe [T... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.25 ML ixekizumab 80 MG/ML Prefilled Syringe [Taltz] RxCUI 2674932

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ixekizumab 1745099
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Taltz 1745104
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ixekizumab Prefilled Syringe 1745111
    • Ixekizumab Injectable Product 1745101
    • Ixekizumab Prefilled Syringe [Taltz] 1745113
    • Taltz Injectable Product 1745107
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Ixekizumab 80 MG/ML [Taltz] SBDC · 1745105
  • Ixekizumab Prefilled Syringe [Taltz] SBDF · 1745113
  • Taltz Injectable Product SBDG · 1745107
  • Taltz BN · 1745104

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 2674932 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00002-1445-09 3 SYRINGE in 1 CARTON (0002-1445-09) / 1 mL in 1 SYRINGE (0... TALTZ Eli Lilly and Company 2016-03-22
00002-1445-11 1 SYRINGE in 1 CARTON (0002-1445-11) / 1 mL in 1 SYRINGE (0... TALTZ Eli Lilly and Company 2016-03-22
00002-1445-27 2 SYRINGE in 1 CARTON (0002-1445-27) / 1 mL in 1 SYRINGE (0... TALTZ Eli Lilly and Company 2016-03-22
00002-1445-61 1 SYRINGE in 1 CARTON (0002-1445-61) / 1 mL in 1 SYRINGE TALTZ Eli Lilly and Company 2016-04-19
00002-7724-11 1 SYRINGE in 1 CARTON (0002-7724-11) / 1 mL in 1 SYRINGE (0... TALTZ Eli Lilly and Company 2016-03-22
00002-7724-99 1 SYRINGE in 1 CARTON (0002-7724-99) / 1 mL in 1 SYRINGE TALTZ Eli Lilly and Company 2018-01-16
00002-8900-11 1 SYRINGE in 1 CARTON (0002-8900-11) / .25 mL in 1 SYRINGE... TALTZ Eli Lilly and Company 2024-02-02
00002-8905-11 1 SYRINGE in 1 CARTON (0002-8905-11) / .5 mL in 1 SYRINGE (... TALTZ Eli Lilly and Company 2024-02-02
Observed labelers: Eli Lilly and Company (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.